This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Northwestern University. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Jacob A Lewis: Innovator in Peptide Amphiphiles
Introduction
Jacob A Lewis is a notable inventor based in Chicago, IL, recognized for his contributions to the field of peptide amphiphiles. With a focus on innovative materials, Lewis has developed technologies that have potential applications in regenerative therapy.
Latest Patents
Lewis holds a patent for "PEGylated peptide amphiphile nanofibers and methods of use." This patent describes peptide amphiphiles (PAs) that can be PEGylated, resulting in nonionic PAs. The invention includes the assembly of these peptide amphiphiles into nanofibers, which may incorporate growth factor proteins that bind to specific sequences on the nonionic PA. Additionally, the nanofibers can include charged peptide amphiphiles that may also be associated with growth factor proteins. The methods of use for these peptide amphiphiles and their compositions are particularly relevant for regenerative therapy.
Career Highlights
Jacob A Lewis is affiliated with Northwestern University, where he continues to advance research in the field of peptide amphiphiles. His work has garnered attention for its innovative approach to material science and its implications for medical applications.
Collaborations
Lewis has collaborated with esteemed colleagues, including Ronit Freeman and Samuel I Stupp, who share his commitment to advancing research in peptide amphiphiles and their applications.
Conclusion
Jacob A Lewis is a significant figure in the realm of peptide amphiphiles, with a patent that showcases his innovative approach to materials science. His work at Northwestern University and collaborations with other researchers highlight his dedication to advancing regenerative therapies.